Get started
Author

Priya Rao

Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder
2014 · Gladell P. Paner, Chandrakanth Annaiah, et al. · Human Pathology · 138
Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma?
2010 · Joshua Weaver, Priya Rao, et al. · Modern Pathology · 128
Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer
2014 · Mahul B Amin, Steven C Smith, et al. · Modern Pathology · 120
Primary Vascular Tumors and Tumor-like Lesions of the Kidney: A Clinicopathologic Analysis of 25 Cases
2010 · Jeffrey G. Brown, Andrew L. Folpe, et al. · The American Journal of Surgical Pathology · 115
Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract
2012 · Christian Gulmann, Gladell P. Paner, et al. · Human Pathology · 87
Angiosarcoma
2013 · Priya Rao, Guy Lahat, et al. · American Journal of Dermatopathology · 65
Primary Ewing Sarcoma / Primitive Neuroectodermal Tumor of the Kidney: A Clinicopathologic Study of 23 Cases
2017 · Paari Murugan, Priya Rao, et al. · Pathology & Oncology Research · 43
‘Difficult to diagnose’ desmoid tumours: a potential role for CTNNB1 mutational analysis
2011 · Chiara Colombo, Svetlana Bolshakov, et al. · Histopathology · 41
PDF
Angiomyolipoma With Epithelial Cysts
2016 · Michael A. LeRoy, Priya Rao · Archives of Pathology & Laboratory Medicine · 23
Influence of Histologic Criteria and Confounding Factors in Staging Equivocal Cases for Microscopic Perivesical Tissue Invasion (pT3a)
2013 · Vijayalakshmi Ananthanarayanan, Yi Pan, et al. · The American Journal of Surgical Pathology · 19
A pilot randomized study evaluating nivolumab (nivo) or nivo + bevacizumab (bev) or nivo + ipilimumab (ipi) in patients with metastatic renal cell carcinoma (MRCC) eligible for cytoreductive nephrectomy, metastasectomy or post-treatment biopsy (Bx).
2019 · Jianjun Gao, Jose A. Karam, et al. · Journal of Clinical Oncology · 13
A pilot randomized study evaluating nivolumab (nivo) or nivo + bevacizumab (bev) or nivo + ipilimumab (ipi) in patients with metastatic renal cell carcinoma (MRCC) eligible for cytoreductive nephrectomy (CN), metastasectomy (MS) or post-treatment biopsy (Bx).
2018 · Jianjun Gao, Jose A. Karam, et al. · Journal of Clinical Oncology · 13
Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma
2025 · Mohammad Jad Moussa, Jaanki Khandelwal, et al. · Journal for ImmunoTherapy of Cancer · 12
PDF
Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer Consortium
2025 · James P Blackmur, J C Koen van der Mijn, et al. · The Lancet Oncology · 11
Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer: Call for a Multidisciplinary Approach
2025 · Rajal B. Shah, Gladell P. Paner, et al. · European Urology · 11
Outcomes of Adults With Ewing Sarcoma Family of Tumors (ESFT) of the Kidney
2014 · Purnima S. Teegavarapu, Priya Rao, et al. · American Journal of Clinical Oncology · 11
Oncologic outcomes and subsequent treatment following organ sparing surgery for penile carcinoma: The University of Texas M.D. Anderson Cancer Center Experience
2021 · Andrea Kokorovic, Jonathan Duplisea, et al. · Urologic Oncology Seminars and Original Investigations · 10
Metastatic Extraosseous Ewing's Sarcoma (EES)/Primitive Neuroectodermal Tumor (PNET) of the Kidney: 8-Year Durable Response After Induction and Maintenance Chemotherapy
2012 · Stephen L. Richey, Priya Rao, et al. · Clinical Genitourinary Cancer · 10
Neuroendocrine neoplasms of the genitourinary tract in adults: cross-sectional imaging spectrum
2016 · Venkata S. Katabathina, Raghu Vikram, et al. · Abdominal Radiology · 9
Extraskeletal Myxoid Chondrosarcoma Presenting as an Intradural Spinal Mass: Report of a Rare Clinical Presentation with an Emphasis on Differential Diagnostic Considerations
2014 · Priya Rao, Rivka R. Colen, et al. · Rare Tumors · 8
PDF
A novel case of glial transdifferentiation in renal medullary carcinoma brain metastasis
2025 · Maria A. Gubbiotti, Ian E. McCutcheon, et al. · Acta Neuropathologica Communications · 3
PDF
Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia
2021 · Kiril Trpkov, Sean R. Williamson, et al. · Modern Pathology · 3
PDF
Outcomes of patients with metastatic renal cell carcinoma and bone metastases in the targeted-therapy era.
2014 · Sarathi Kalra, Jonathan Verma, et al. · Journal of Clinical Oncology · 2
Molecular profiling of renal medullary carcinoma to reveal frequent alterations in chromatin remodeling genes and to identify EZH2 as a relevant therapeutic target.
2016 · Jianjun Gao, Gabriel G. Malouf, et al. · Journal of Clinical Oncology · 1
36International neoadjuvant kidney cancer consortium guidelines on assessing pathological response after neoadjuvant therapy in kidney cancer
2025 · James Jones, James Blackmur, et al. · The Oncologist
PDF
Works count: 45
Citation count: 896
H-index: 12
I10-index: 18
Year
Topic
Type